BMPER Protein Is a Negative Regulator of Hepcidin and Is Up-regulated in Hypotransferrinemic Mice

The BMP/SMAD4 pathway has major effects on liver hepcidin levels. Bone morphogenetic protein-binding endothelial cell precursor-derived regulator (Bmper), a known regulator of BMP signaling, was found to be overexpressed at the mRNA and protein levels in liver of genetically hypotransferrinemic mice (Trfhpx/hpx). Soluble BMPER peptide inhibited BMP2- and BMP6-dependent hepcidin promoter activity in both HepG2 and HuH7 cells. These effects correlated with reduced cellular levels of pSMAD1/5/8. Addition of BMPER peptide to primary human hepatocytes abolished the BMP2-dependent increase in hepcidin mRNA, whereas injection of Bmper peptide into mice resulted in reduced liver hepcidin and increased serum iron levels. Thus Bmper may play an important role in suppressing hepcidin production in hypotransferrinemic mice. Background: The mechanism by which anemia results in lowered hepcidin levels is not clear. Results: Bone morphogenetic protein (BMP)-binding endothelial cell precursor-derived regulator (BMPER), a known BMP antagonist, was found to be up-regulated in anemic Trfhpx/hpx mice and to suppress hepcidin transcription both in vivo and in vitro. Conclusion: BMPER is involved in suppressing hepcidin levels in Trfhpx/hpx mice. Significance: BMPER is a novel regulator of hepcidin and iron metabolism.